Outcome of intralesional saline for the management of atrophic acne scars
DOI:
https://doi.org/10.66344/jpad.v32i2.1939Abstract
Objective To determine mean satisfaction score with intralesional saline for the management of atrophic acne scars.
Methods In this descriptive case series, 50 patients of age 16-50 years, fulfilling the inclusion and exclusion criteria, were enrolled. After local anesthesia with xylocain, the saline (0.9% NaCI) was injected intra and sub-dermally with a 31-gauge needle. The frequency of administration was once weekly for five weeks. Satisfaction level of patients was assessed on visual scale (VS).SPSS 20 was used for analyzing data.
Results Mean age of the patients was 26.8±6.0 year. Out of 50 patients, 30 (60%) were males while 20 (40%) were females. Mean duration of acne scar was 26.2±16.8 months. Types of scars were: ice pick 42 (84%), boxcar 39 (78%), and rolled scars 37 (74%). Mean VS at baseline was 6.92±1.49 and after treatment it was 10.1±1.37. This increase in VS was statistically significant (p<0.001).
Conclusion The response to intralesional saline was convincing in all types of atrophic acne scars. The study demonstrated that saline can be an effective and safe therapeutic modality for all types of atrophic acne scars.
Key words
Atrophic acne scars, intralesional saline, efficacy.
References
1. Gerald O'Daniel T. Multimodal management of atrophic acne scarring in the aging face. Aesthet Plast Surg. 2011;35:1143-50.
2. Capitanio B, Sinagra JL, Bordignon V, Fei PC, Picardo M, Zouboulis CC. Underestimated clinical features of postadolescent acne. J Am Acad Dermatol. 2010;63:782-8.
3. Taub AF, Garretson CB. Treatment of acne scars of skin type II to V by sublative fractional bipolar radiofrequency and bipolar radiofrequency combined with diode laser. J Clip Aesthet Dermatol. 2011;4:18-27.
4. Munavalli GS, Smith S, Maslowski JM, Weiss RA. Successful treatment of depressed, distensible acne scars using autologous fibroblasts: A multi-site, prospective, double blind, placebo-controlled clinical trial. Dermatol Surg. 2013;39:1226-36.
5. Lauermann FT, Almeida Jr HLd, Duquia RP, Souza PRMd, Breunig JdA. Acne scars in 18-year-old male adolescents: a population-based study of prevalence and associated factors. An Bras Dermatol. 2016;91:291-5.
6. Layton A, Dreno B, Finlay AY. New Patient-Oriented Tools for Assessing Atrophic Acne Scarring. Dermatol Ther. 2016;6:219-33.
7. Fife D, Clin J. Practical evaluation and management of atrophic acne scars: tips for the general dermatologist. Aesthet Dermatol. 2011;4:50-7.
8. Werschler WP, Herdener RS, Ross VE, Zimmerman E. Treating Acne Scars: What's New? Consensus from the Experts. J Clin Aesthet Dermatol. 2015;8:2-8.
9. Hessoin MT, Grabber EM. Atrophic acne scarring: a review of treatment options. J Clin Aesthet Dermatol. 2015;8:50-8.
10. Bagherani N, Smoller BR. Introduction of a novel therapeutic option for atrophic acne scars: saline injection therapy. Glob Dermatol. 2015;2:225-7.
11. Cunliffe WJ, Gould, DJ. Prevalence of facial acne vulgaris in late adolescence and in adults. Br Med J. 1979;1:1109–10.
12. Kwok T, Rao J. Laser management of acne scarring. Skin Therapy Lett. 2012;17:4-6.
13. Aneela Asghar, Zahid Tahir, Aisha Ghias, Usma Iftikhar, Tahir Jameel Ahmad. Efficacy and Safety of Intralesional Normal Saline in Atrophic Acne Scars. Annals KEMU. 2019;25(2).
14. Khan S, Ghafoor R, Kaleem S. Efficacy of Saline Injection Therapy for Atrophic Acne Scars. J Coll Physicians Surg Pak. 2020;30(04):359-63.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Mah-e-Neema Asghar
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.
